AAV CMV-driven AcrIIC3-scaffold (2xBsmBI sites) Citations (1)

Originally described in: Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD, Aschenbrenner S, Grosse S, Rapti K, Domenger C, Fakhiri J, Mastel M, Borner K, Eils R, Grimm D, Niopek D Nucleic Acids Res. 2019 Apr 15. pii: 5458120. doi: 10.1093/nar/gkz271. PubMed Journal

Articles Citing AAV CMV-driven AcrIIC3-scaffold (2xBsmBI sites)

Articles
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein. Hoffmann MD, Mathony J, Upmeier Zu Belzen J, Harteveld Z, Aschenbrenner S, Stengl C, Grimm D, Correia BE, Eils R, Niopek D. Nucleic Acids Res. 2021 Mar 18;49(5):e29. doi: 10.1093/nar/gkaa1198. PubMed Associated Plasmids CNC3 (CASANOVA-C3) CNC3G (CASANOVA-C3 with glycine linkers)

If you have published an article using this material, please email us at [email protected] to have your article added to this page.